QualityMetric Health Outcomes Solutions
Smart Measurement News: July 2005


 

QualityMetric Generic Health Surveys:
SF-36®, SF-36v2™, SF-12®, SF-12v2™, SF-10™ for Children, and SF-8™

The Harvard School of Public Health and QualityMetric Offer Accredited Patient-reported Outcome (PRO) Programs
Recent Publications/Presentations
Upcoming Publications/Presentations
Careers at QualityMetric

The Harvard School of Public Health and QualityMetric Offer Accredited Programs on Patient-reported Outcomes (PROs):

1. Measurement, Design, and Analysis Methods for Health Outcomes Research

Offered by the Harvard School of Public Health, with the Participation and Support of QualityMetric Health Outcomes Solutions

August 22 - 24, 2005

A continuing professional education program designed for:

  • Pharmaceutical marketing and outcomes professionals responsible for the substantiation of product marketing and label claims and the facilitation of regulatory approval

  • Health care providers, disease management program administrators, and researchers utilizing outcomes data for clinical decision-making and population management

  • Hospital/health system administrators and clinicians involved in outcomes management

  • Administrators from third party payers, benefit plan sponsors, managed care, and insurance companies utilizing outcomes data to measure program effectiveness

  • Health care professionals looking to broaden understanding and skills relative to health outcomes measurement

Held on the Harvard School of Public Health Campus in Boston, MA, this program will be lead by noted Harvard professors with special presentation by a QualityMetric Measurement Scientist. Capacity is limited and filling up fast!

For complete program information or to register, CLICK HERE, and please be sure to mention this Reference Code: MDA05-QMEM1 in all correspondence.

2. Innovative Strategies for Health Outcomes Research and Management in the Pharmaceutical Industry

A customized, on-site program designed for pharmaceutical, biotechnology and medical device companies looking to maximize the value of patient-reported outcomes (PROs) measurement. Useful for initiating dialogue between clinical, marketing, product development, outcomes, and pharmacoeconomic groups. Click here to register for information on program content and costs.

Recent Publications/Presentations

  • Development of a prototype aggregate level report for Asthma-CAT. Presentation at the annual meeting of the Society of Behavioral Medicine. Anatchkova M, Turner-Bowker D, Saris-Baglama R, Mosen D, Ware JE, Jr. Society of Beahvioral Medicine. 2005 Click here to view presentation.

  • An observational study of health-related quality of life and pain outcomes in chronic low back pain patients treated with fentanyl transdermal system. Mark Kosinksi, Jeff Schein, Sue Vallow, et al. Current Medical Research and Opinion 2005;21(6):849-862. Click here for article.

  • Development and validation of the Pain Impact Survey. Schwartz C, Saris-Baglama, Becker J, Kosinksi M, Bjorner JB. Journal of Pain 2005;6(3):s71. Click here for abstract.

  • Item response theory and computerized adaptive testing: Implications for outcomes measurement in rehabilitation. Ware JEJ, Sinclair SJ, Gandek B, Bjorner JB. Rehabilitation Psychology 2005; 50(1):71-78. Click here for article.

  • Development and Preliminary Evaluation of a Computerized Adaptive Assessment for Asthma (ASTHMA-CAT).Presentation in the Poster Program at the AcademyHealth 2005 Annual Research Meeting. Turner-Bowker, DM, Saris-Baglama, RN, Anatchkova M, & Mosen, D. Click here for poster.

Upcoming Publications/Presentations

  • American Psychological Association (APA), August 18-20 Washington, DC. QualityMetric's CEO, John Ware, Jr., PhD, along with Mark T. Barisa, PhD of Memphis Veterans Affairs Medical Center, and Charles D. Callahan, PhD of Memorial Medical Center, will present Six P's of Outcomes Measurement at an Invited Symposium during the 2005 American Psychological Association Convention. Dr. Ware will be discussing Computerized Adaptive Testing: Implications for Clincial Outcomes Measurement in Rehabilitation Psychology. To learn more about the convention, please click here.

  • Computerized Adaptive Testing Offers an Efficient Approach to the Assessment of Osteoarthritis Impact. Mark Kosinski, Jakob B. Bjorner, John E. Ware, Jr., Elizabeth Sullivan, Walter L. Straus. Journal of Clinical Epidemiology (in press).

  • Impact of fibromyalgia on health-related quality of life before and after treatment with tramadol/acetaminophen. Robert Bennett, Jeff Schein, Mark Kosinski, et al. Arthritis and Rheumatism (in press).

Careers at QualityMetric

Recruitment is currently underway for the following careers (CLICK BELOW for more information):
 

About QualityMetric

QualityMetric Health Outcomes Solutions has integrated the consumer’s voice into health care decision-making with self-reported generic and disease-specific health outcomes surveys used worldwide to measure health status with scientific validity in clinical practice, disease management, population monitoring, clinical trials, and direct-to-consumer marketing. Founded in 1997 by John E. Ware, Jr., Ph.D., principal developer of the SF-36®, SF-12®, and SF-8™ Health Surveys, QualityMetric’s scientific expertise has dramatically evolved the value and precision of health-related quality of life measurement while our technology applications, including the world’s first computerized dynamic health assessments (DYNHA®), have broadened the options for administration.
www.qualitymetric.com
 

The SF-36® and SF-12® Health Surveys are registered trademarks of the Medical Outcomes Trust.
The SF-36v2™, SF12v2™, SF-10™ for Children, and SF-8™ Health Surveys are trademarks of QualityMetric Incorporated, 640 George Washington Highway, Suite 201, Lincoln, Rhode Island 02865.

 
 

This email has been circulated by BioPortfolio Ltd on behalf of QualityMetrics Inc. As a registered user of the BioPortfolio web sites and as a professional in the life sciences, you were selected to receive this message in the genuine belief that it would be of interest to you.

Subscriber information:
To subscribe to the BioPortfolio Bulletin click here and send or 

To unsubscribe to the BioPortfolio Bulletin click here and send. 

If your email has changed please email peter.barfoot@bioportfolio.com with a list of your email addresses and we will manually unsubscribe for you.  Thank you for your understanding.

Disclaimer:
BioPortfolio Limited and its agents used their best efforts in collecting and preparing the information published herein. However, BioPortfolio does not assume, and hereby disclaims, any and all liability for any loss or damage caused by errors, whether such errors resulted from negligence, accident, or other causes. All rights reserved. ©2005 BioPortfolio Limited

BioPortfolio is the essential web resource for scientists, executives, investors, the public and the patient with an interest in who, what, where, when and why biotechnology will impact on our lives. We have created proprietary databases and search engines that will support your business and private interests in the most exiting technology of the 21st Century. BioPortfolio provides 14 Channels: www.bioportfolio.com/ 

BioPortfolio Limited, Wessex Barn, Frampton, Dorset, DT2 9NB, UK